Sort
50,496 grants matching “lung cancer”
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
$966,615Spartanburg Regional Medical Center · U10 · FY2000 · CA
Quit-smoking program for lung cancer patients'families
$966,572Duke University · U01 · FY2005 · CA
Outcomes in Rheumatic Diseases
$966,532Michael Ward · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR
Multi-organ metastatic breast cancer cell-based assay platform that models organotropic metastases using patient organoids in human tissue-derived ECMs to accelerate anti-metastatic drug development
$966,420John David O'Neill · Xylyx Bio, Inc. · R44 · FY2025 · CA
Genetic Toxicity Testing Services for the NTP
$966,181Les Recio · Integrated Laboratory Systems, Llc · N01 · FY2017 · ES
Outcomes in Rheumatic Diseases
$965,936Michael Ward · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2009 · AR
Impact of Hearing Loss and Tinnitus in Cancer Survivors
$965,864Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2018 · CA
Targeting the MYC Pathway for the Treatment of Cancer
$965,767Dean W Felsher · Stanford University · R35 · FY2025 · CA
Epigenetic Alterations Induced by Tobacco Smoke
$965,749David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cancer Risk Reduction and Diet: A Cohort Study of Women
$965,732Wei Zheng · Vanderbilt University · R37 · FY2010 · CA
ARKANSAS SPECIAL POPULATIONS ACCESS NETWORK (A-SPAN)
$965,549University Of Arkansas Med Scis Ltl Rock · U01 · FY2004 · CA
Factors for Epigenetic Silencing of Lung Cancer Genes
$965,513Lovelace Biomedical &Environmental Res · U01 · FY2005 · CA
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention
$965,430Jennifer S Haas · Massachusetts General Hospital · U01 · FY2019 · CA
Clinical Protocol and Data Management (Core 012)
$965,073Dan Toby Vogl · University Of Pennsylvania · P30 · FY2020 · CA
Libby Epidemiology Research Program
$965,000Jaime Szeinuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · TS
Libby Epidemiology Research Program
$965,000Stephen Michael Levin · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · TS
Libby Epidemiology Research Program
$965,000Stephen Michael Levin · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · TS
Libby Epidemiology Research Program
$965,000Raja M. Flores · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · TS
Libby Epidemiology Research Program
$965,000Raja M Flores · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · TS
Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors
$964,830Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
$964,611Julien Sage · Stanford University · R35 · FY2021 · CA
Improved Treatment of Colorectal Cancer with CF10
$964,465William H Gmeiner · Deep Creek Pharma, Llc · R42 · FY2023 · CA
Preclinical development of AlaTIMP-2 as an cancer therapeutic
$964,392William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER
$964,370University Of Alabama At Birmingham · N01 · FY2000 · CN
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$964,277Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · CA